|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
IMMUNOBIOLOGY
From the Department of Hematology and Oncology, and the
Department of Microbiology, Osaka University Graduate School of
Medicine, Osaka, Japan; Department of Pathology, Hyogo College of
Medicine, Hyogo, Japan; and the Department of Allergy and
Rheumatology, University of Tokyo, Tokyo, Japan.
Stem cell factor (SCF) has crucial roles in proliferation,
survival, and differentiation of hematopoietic stem cells and mast cells through binding to c-Kit receptor (KIT). Chemotaxis is another unique function of SCF. However, little is known about the
intracellular signaling pathway of SCF/KIT-mediated cell migration. To
investigate the signaling cascade, we made a series of 22 KIT mutants,
in which tyrosine (Y) residue was substituted for phenylalanine (F) in
the cytoplasmic domain, and introduced into BAF3 cells or 293T cells.
On stimulation with SCF, BAF3 expressing KITWT(WT) showed
cell migration and Ca2+ mobilization. Among 22 YF mutants,
Y567F, Y569F, and Y719F showed significantly reduced cell migration and
Ca2+ mobilization compared to WT. In Y567F, Lyn activation
on SCF stimulation decreased and C-terminal Src kinase (Csk)
suppressed KIT-mediated Ca2+ influx and cell migration,
suggesting that Y567-mediated Src family kinase (SFK) activation leads
to Ca2+ influx and migration. Furthermore, we found that
p38 mitogen-activated protein kinase (p38 MAPK) and Erk1/2 were also
regulated by Y567/SFK and involved in cell migration, and that
p38 MAPK induced Ca2+ influx, thereby leading to Erk1/2
activation. In Y719F, the binding of phosphatidylinositol 3'-kinase
(PI3K) to KIT was lost and KIT-mediated cell migration and
Ca2+ mobilization were suppressed by PI3K chemical
inhibitors or dominant-negative PI3K, suggesting the involvement of
Y719-mediated PI3K pathway in cell migration. Combination of Csk and
the PI3K inhibitor synergistically reduced cell migration, suggesting
the cooperation of SFK and PI3K. Taken together, these results indicate
that 2 major KIT signaling pathways lead to cell migration, one is
Y567-SFK-p38 MAPK-Ca2+ influx-Erk and the other is
Y719-PI3K-Ca2+ influx.
(Blood. 2002;99:3342-3349) c-Kit is a receptor tyrosine kinase (RTK),
which constitutes a type III RTK subfamily with the receptors for
platelet-derived growth factor (PDGF), colony-stimulating factor 1 (CSF-1), and flt-3 ligand.1,2 The type III RTKs are
characterized by an extracellular domain with 5 immunoglobulinlike
domains and a cytoplasmic domain consisting of a kinase domain that is
interrupted by a kinase insert. c-Kit (KIT) and its ligand stem cell
factor (SCF) play an important role in hematopoiesis, melanogenesis,
and gametogenesis,3 as has been clearly shown by loss of
function mutations of c-kit gene. In addition,
c-kit gene product has been associated with various forms of
neoplasms. Activating mutants of KIT, either in the juxtamembrane
domain or the catalytic domain, were identified as the cause for
transformation of hematopoietic stem cells, mast cells, and
gastrointestinal stromal cells.4-10 Thus, KIT/SCF has pleiotropic functions such as proliferation, survival, differentiation, and transformation. In this report, we focus on SCF/KIT-mediated cell
migration, which is also a characteristic function of SCF in
hematopoietic stem cells and mast cells,11-13 and has
critical roles in immunity, metastasis, and development.
On ligand stimulation, KIT receptors dimerize, activate its intrinsic
tyrosine kinase, and autophosphorylate. The phosphorylated KIT receptor
generates binding sites for SH2 domain-containing proteins, which
include proteins of the p21Ras-mitogen-activated protein kinase (MAPK)
pathway,14 the p85 subunit of phosphatidylinositol 3'
kinase (PI3K),15 phospholipase C- Reagents and antibodies
Construction of expression plasmids
Cells and transfection The IL-3-dependent murine pro-B cell line, BAF3, was maintained in RPMI 1640 medium supplemented with 10% fetal calf serum (FCS) and 1 ng/mL rmIL-3. Transfection of BAF3 cells was performed by electroporation. Following gene transfer, cells were cultured in IL-3-containing medium for 24 hours and then selected in G418 at a concentration of 1 mg/mL. Multiple clones were expanded for further analysis. Human embryonic kidney 293T cell was transfected by the calcium phosphate method as described previouly.23 Two days after transfection, the cells were used for further analysis. To detect KIT proteins on the cell surface, cells were treated for 30 minutes at 4°C with biotin-conjugated rat antimurine KIT antibody (Immunotech, Marseille, France). After washing, cells were incubated for 30 minutes at 4°C with a 1:40 dilution of avidin-fluorescein isothiocyanate (FITC; Becton Dickinson, San Jose, CA). Samples were analyzed using a FACSCalibur (Becton Dickinson).Immunoprecipitation and Western blot analysis BAF3 cells transfected with c-kit constructs (BAF3/KIT) were starved from IL-3 and serum for 12 hours in RPMI 1640 medium supplemented with 0.1% FCS. Subsequently, cells were resuspended in 1 mL medium for 5 minutes at 37°C with or without 100 ng/mL SCF, washed twice with ice cold phosphate-buffered saline (PBS), and lysed with buffer containing 50 mM HEPES (pH 7.4), 10% glycerol, 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, 1 mM EGTA, 50 µM ZnCl2, 25 mM NaF, proteinase inhibitors (Complete, Boehringer Mannheim, Mannheim, Germany), 1 µM pepstatin, and 1 mM sodium orthovanadate. Cell lysates were clarified at 20 000g for 20 minutes. For immunoprecipitation, cell lysates were incubated with rabbit polyclonal antibody to murine KIT and with Protein A/G-Plus-Sepharose (Santa Cruz). The immunoprecipitates were washed 3 times with lysis buffer. Immunoprecipitates and total lysates were resuspended in sodium dodecyl sulfate (SDS) sample buffer, heated and separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE). Gels were blotted on Immobilon P membrane (Millipore, Bedford, MA) and stained with the indicated antibody. Antibody binding was detected by incubation with a horseradish peroxidase (HRP)-labeled secondary antibody followed by chemiluminescence detection (ECL-Plus, Amersham Pharmacia Biotech, Buckinghamshire, United Kingdom).In vitro 2-chamber migration assay The modified Boyden chamber assay in a 24-well chemotaxis chamber (5-µm pore size, Kurabow, Osaka, Japan) was used to measure SCF-induced cell migration. The upper and lower chambers were filled with RPMI 1640 medium supplemented with 10% FCS and various concentrations of SCF. A total of 3 × 105 IL-3-starved BAF3/KIT cells were plated in each of the upper chamber. Chambers were incubated for 6 hours at 37°C in a CO2 incubator. Cells migrating into the lower chamber were counted in the flow cytometry by passing each sample at the same predetermined time and flow condition as previously described.11Intracellular Ca2+ measurement The measurements of intracellular Ca2+ was as done as described previously.24 In short, cells were washed twice in Hepes-buffered Krebs solution, which consisted of 124 mM NaCl, 5.4 mM KCl, 0.8 mM MgCl2, 1.8 mM CaCl2, 10 mM glucose, and 25 mM Hepes (pH 7.4; HBKS). Then, a total of 107 cells were incubated in 1 mL HBKS containing 5 µM Indo 1-AM for 30 minutes at 37°C in the dark. The cells were subsequently washed twice with HBKS and resuspended at 2.5 × 106 cells/mL. The cell suspension was plated in a continuously stirred cuvette at 37°C in a CAF-110 fluorometer (Jasco, Tokyo, Japan). Fluorescence was monitored at an excitation wavelength of 355 nm and emission wavelengths of 405 nm and 485 nm. The data are presented as the relative ratio of fluorescein excited at 405 to 485 nm.Statistical analysis Comparisons between other groups were made using an unpaired Student t test (2-tails).
SCF induces cell migration and increases in the intracellular Ca2+ The chemotactic property of BAF3/KITWT (BAF3/WT) against SCF is presented as a checkerboard diagram (Table 1). Maximal response was obtained with a concentration of 30 ng/mL SCF in the lower chamber. Because Ca2+ is the key mediator of cell movement, we measured SCF-induced intracellular change of Ca2+ in BAF3/WT cells using Indo1-AM. Following SCF stimulation, BAF3/WT cells exhibited a prompt peak and subsequently sustained increase of Ca2+. The Ca2+ influx was dependent on SCF concentration within a range from 10 to 100 ng/mL. This Ca2+ influx peak was gradual as compared with stromal cell-derived factor-1
(SDF-1) (Figure 1). Then, we examined
the effect of the intracellular Ca2+ chelator BAPTA-AM on
SCF-induced Ca2+ mobilization and cell migration. The
pretreatment of cells with BAPTA-AM also inhibited SCF-induced cell
migration in a dose-dependent manner (Figure
2A). The pretreatment of cells with
BAPTA-AM dose dependently attenuated SCF-induced intracellular
Ca2+ mobilization as shown in Figure 2B.
Reduced Ca2+ mobilization and cell migration in Y567F, Y569F, and Y719F cells As shown in Figure 3A, KIT contains 22 tyrosine (Y) residues in the cytoplasmic domain. To determine which tyrosine residue(s) is involved in Ca2+ mobilization and cell migration, we constructed a series of 22 single YF mutants for all these tyrosine residues. On transient transfection into 293T cells, Y567F, Y569F, and Y719F, respectively, showed 73%, 60%, and 54% reduction of Ca2+ mobilization when compared with WT (Figure 3B). To further examine the effects of these YF conversions in stable cell clones, we transfected these constructs into murine IL-3-dependent BAF3 cells that had no intrinsic KIT expression. The surface expressions and ligand-induced autophosphorylations of KIT were observed at the same level in BAF3 clones expressing WT or each mutant (data not shown). Similar to the results of 293T cells, Ca2+ influx was suppressed in BAF3 expressing Y567F (BAF3/Y567F), BAF3/Y569F and BAF3/Y719F (data not shown). SCF-induced cell migration was decreased for 85%, 70%, and 58% in BAF3/Y567F, BAF3/Y569F, and BAF3/Y719F mutants, respectively, as compared to BAF3/WT, which were similar to the reduction rate of Ca2+ mobilization (Figure 3C).
SCF-induced Ca2+ influx and cell migration is regulated by SFK Consistent with previous reports that indicated the close relationship between Y567 and SFK, we found that in 293T cells expressing Y567F mutant (293T/Y567F), SCF-induced Lyn activation was remarkably reduced as compared to 293T/WT (Figure 4A). To determine if SFK activity is involved in SCF-stimulated Ca2+ mobilization and cell migration, SFK activity was inhibited specifically by expression of Csk, which is the negative regulator of SFK. We transfected WT-Csk, Csk( ) (kinase dead), or mCsk (constitutive active) into BAF3 cells
and 293T cells, with c-kit WT. Csk proteins were highly expressed as
shown in Figure 4B. In both cell lines, WT-Csk inhibited SCF-induced
Ca2+ influx significantly. The suppression of
Ca2+ influx was more prominent in mCsk transfectants. In
contrast, expression of Csk() did not suppress Ca2+
influx, indicating that Csk activity plays an important role in
Ca2+ influx in the signaling cascades mediated by c-Kit
(Figure 4C). We next examined the effect of WT-Csk, Csk(), and mCsk
on cell migration by using stably transfected BAF3 cells. WT-Csk
inhibited cell migration and mCsk inhibited more profoundly than WT-Csk (Figure 4D). These findings suggested that SFK may regulate SCF-induced Ca2+ influx and cell migration.
SFK regulates cell motility through Erk and p38 MAPK We next explored how Csk affects SCF-mediated signal transduction, thereby leading to cell migration. As shown in Figure 5A, in any Csk transfectant there was no difference in the activation of Akt. On the other hand, Csk and mCsk inhibited SCF-mediated activation of p38 MAPK and MEK1/2 (Figure 5A). SCF-mediated activations of MEK1/2 and p38 MAPK were also significantly reduced in BAF3/Y567F, where SCF-induced SFK activation was suppressed (Figure 5B). Moreover, MEK1/2 inhibitor U0126 and p38 MAPK inhibitor SB203580 suppressed cell migration dose dependently as shown in Figure 6. Both U0126 and SB203580 did not affect cell viability at these concentrations. These results indicate that Y567 of KIT mediates MEK/Erk and p38 MAPK signaling through SFK and regulates SCF-induced cell migration.
p38 MAPK induced Ca2+ mobilization We next examined the relationship between Ca2+ mobilization, Erk, and p38 MAPK. After treatment of BAF3/WT cells with U0126 or SB203580, Ca2+ influx on SCF stimulation was measured. As shown in Figure 7A, p38 MAPK inhibitor SB203580 suppressed Ca2+ influx, but MEK inhibitor U0126 did not. Furthermore, we examined the effect of the intracellular Ca2+ chelator, BAPTA-AM on SCF-induced activation of MEK1/2 and p38 MAPK. As shown in Figure 7B, treatment of the cells with BAPTA-AM remarkably reduced the activation of MEK1/2, but did not suppress the activation of p38 MAPK. These data indicated that in SCF signaling, SFK-activated P38 MAPK may induce Ca2+ mobilization, resulting in the activation of MEK/ Erk pathway.
PI3K regulates SCF-induced Ca2+ influx and cell migration Y719F abolished the binding of PI3K to KIT (Figure 8A). In BAF3/Y719F, Ca2+ influx and cell migration were impaired about 50% as compared with WT. To explore the involvement of PI3K in SCF-induced cell migration, we tested specific PI3K inhibitors, wortmannin and LY294002, both of which inhibited cell migration in a concentration-dependent manner (Figure 8B). Furthermore, we introduced an expression vector of dominant-negative PI3K or an empty control vector into BAF3/WT cells. Dominant-negative PI3K expression inhibited SCF-induced PI3K activity by about 85% (data not shown). BAF3/WT cell expression of dominant-negative PI3K inhibited significantly Ca2+ influx and cell migration in BAF3/WT cells (Figure 8C,D).
SFK and PI3K cooperate for cell migration To examine the interaction between SFK and PI3K, we analyzed the migration of BAF3/WT expressing mCsk (BAF3/WT/mCsk) in the presence of the PI3K inhibitor LY294002. The migration of BAF3/WT/mCsk was reduced to about 50% of the BAF3/WT cells. When BAF3/WT/mCsk cells were treated with LY294002, the migration response was further inhibited and reduced to about 15% of BAF3/WT (Figure 9). These results suggested that both SFK and PI3K cooperate for SCF-mediated cell migration.
Migration is one of the unique and important cell functions undertaken by SCF/KIT system. Much effort has been done to clarify signal transduction leading to SCF/KIT-mediated proliferation and survival, but the signaling mechanism in SCF-mediated cell migration has not been clarified yet. In this study, we determined several critical signaling molecules in SCF-induced cell migration, using a series of 22 YF mutants of KIT. First, we found that intracellular Ca2+ mobilization plays a pivotal role in SCF-mediated cell migration. It has been reported that Ca2+ mobilization plays a critical role in cell migration of keratinocytes and neutrophils.25,26 SCF-induced Ca2+ mobilization was not significantly impaired by most single YF substitution mutants, but it was remarkably abrogated by Y567F and moderately by Y569F and Y719F. In Y567F, Y569F, and Y719F mutants, cell motilities were also inhibited similarly, corresponding to the reduction levels of Ca2+ mobilization. Moreover, Ca2+ chelator completely abolished the migratory activity. These results indicated the importance of Ca2+ mobilization in SCF-mediated cell migration, which are largely mediated by Y567, Y569, and Y719 of KIT. Second, we found that Y567/SFK play an important role in SCF-mediated Ca2+ mobilization and cell migration. The previous study showed that Y567 of KIT is the binding site of SFK.27-29 It was also shown that SFK plays an important role in PDGF-induced cell migration.30,31 Therefore, we investigated the roles of SFK on SCF/KIT-mediated Ca2+ mobilization and cell migration. In disagreement with previous reports,27-29 we could not find the direct binding of Lyn or Fyn with KIT after SCF stimulation in either BAF3/KIT cells or 293T/KIT cells (data not shown). However we could show the activation of SFK, Lyn, in 293T/KIT cells after SCF stimulation; this ligand-dependent activation of Lyn was remarkably reduced by the Y567F substitution, indicating that Y567 is critical for SFK activation. Although previous reports determined the importance of SFK by so-called specific SFK inhibitors PP1 or PP2, they might not be suitable for analyzing KIT signaling, because these inhibitors abolished ligand-dependent KIT autophosphorylation and kinase activity at the concentration of 10 to 30 µM in BAF3 cells (data not shown). This observation was supported by the finding that PDGF receptor activation was inhibited by PP1.32 Therefore, we further investigated the role of SFK in cells overexpressing Csk. In the previous study, we showed that Csk and mCsk suppressed the activation of SFKs specifically.33,34 In this study, overexpression of Csk or mCsk inhibited SCF-induced Ca2+ mobilization and cell migration in BAF3/KIT cells. These results strongly suggested that SFK is a critical signaling pathway for SCF-mediated cell migration and Ca2+ mobilization. In Y567F cells, the activations of p38 MAPK and Erk1/2 were significantly impaired. Expressions of Csk or mCsk also inhibited the activation of p38 MAPK and Erk1/2, suggesting the involvement of SFK in their activations. Furthermore, p38 MAPK inhibitor, SB203580 or MEK1/2 inhibitor, U0126, suppressed cell migration significantly. These data suggested that SFK regulates cell migration through p38 MAPK and Erk1/2. Regarding the relationship between p38 MAPK and Ca2+ mobilization, SB203580 impaired SCF-induced Ca2+ influx, but intracellular Ca2+ chelator BAPTA-AM did not suppress p38 MAPK activation. On the other hand, U0126 did not impair Ca2+ influx, but Ca2+ chelator suppressed MEK1/2 activation. These data indicate that p38 MAPK induces Ca2+ mobilization, thereby resulting in Erk1/2 activation. Previous reports showed that Ca2+ influx activates p38 MAPK and Erk1/2 in human neutrophils or PC12 cells.35,36 Recently, it was reported that Y568 of human KIT (corresponding to murine Y567) is important of SFK activation and Shc phosphorylation resulting in Ras/Erk2 activation,37 and p38 MAPK was involved in SCF-mediated cell migration.22 In this report, for the first time, we showed that not only p38 MAPK but also Erk1/2 was involved in SCF-mediated cell migration, and that both MAPKs differentially transduce the signaling from Y567-induced SFK activation to Ca2+ influx and cell migration. Finally, we showed the Y719/PI3K pathway also regulates SCF-mediated cell migration. Consistent with the previous report,15 we confirmed that Y719 was the binding site for PI3K. In PDGF-induced chemotaxis, PI3K is regarded as a major signaling pathway of Ca2+ influx leading to cell migration.38-40 In our study, Y719F mutant exhibited less effective inhibition of Ca2+ influx and cell migration than Y567F, suggesting that SFK has a more essential role than PI3K. The importance of PI3K was confirmed by the inhibition studies with chemical inhibitors and dominant negative PI3K. BecauseY719F did not show the impaired activation of p38 MAPK or Erk1/2, which were suppressed by the inhibition of SFK, PI3K may act by a different pathway from SFK, for the cell migration followed by Ca2+ mobilization. Furthermore, the PI3K inhibitor and Csk showed synergistic suppression of cell migration, suggesting the cooperation of SFK and PI3K in SCF-mediated migration. In summary, this study has provided evidence that SFK and PI3K cooperatively contribute to SCF-mediated cell migration through Ca2+ mobilization, and the signaling of SFK is transduced sequentially from p38 MAPK, Ca2+ influx, and then to Erk1/2. Many kinds of growth factors can activate SFK, Erk1/2, p38 MAPK, or PI3K, but this does not always lead to the cell motility. Therefore, the coordination of this signaling by scaffolding proteins could be important for SCF-mediated chemotaxis. Future studies focused on this point will further clarify the signaling mechanism of SCF/KIT-mediated cell migration.
We thank Dr Koji Hashimoto for great help of making YF substitution mutants and their expression vectors, and we thank Noriko Kikunaga for her excellent experimental assistance.
Submitted October 30, 2001; accepted December 28, 2001.
Supported in part by grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology, the Japanese Ministry of Health, Labor and Welfare, and the Japan Society for Promotion of Science.
The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734.
Reprints: Yuzuru Kanakura, Department of Hematology and Oncology, Osaka University Graduate School of Medicine, 2-2, Yamada-oka, Suita, Osaka 565-0871, Japan; e-mail: kanakura{at}bldon.med.osaka-u.ac.jp.
1.
Qiu FH, Ray P, Brown K, et al.
Primary structure of c-kit: relationship with the CSF-1/PDGF receptor kinase family 2. Yarden Y, Kuang WJ, Yang-Feng T, et al. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J. 1987;6:3341-3351[Medline] [Order article via Infotrieve]. 3. Witte ON. Steel locus defines new multipotent growth factor. Cell. 1990;63:5-6[CrossRef][Medline] [Order article via Infotrieve]. 4. Furitsu T, Tsujimura T, Tono T, et al. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest. 1993;92:1736-1744.
5.
Kitayama H, Kanakura Y, Furitsu T, et al.
Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines.
Blood.
1995;85:790-798
6.
Kitayama H, Tsujimura T, Matsumura I, et al.
Neoplastic transformation of normal hematopoietic cells by constitutively activating mutations of c-kit receptor tyrosine kinase.
Blood.
1996;88:995-1004 7. Hashimoto K, Tsujimura T, Moriyama Y, et al. Transforming and differentiation-inducing potential of constitutively activated c-kit mutant genes in the IC-2 murine interleukin-3-dependent mast cell line. Am J Pathol. 1996;148:189-200[Abstract]. 8. Tsujimura T. Role of c-kit receptor tyrosine kinase in the development, survival and neoplastic transformation of mast cells. Pathol Int. 1996;46:933-938[Medline] [Order article via Infotrieve].
9.
Hirota S, Isozaki K, Moriyama Y, et al.
Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.
Science.
1998;279:577-580 10. Nishida T, Hirota S, Taniguchi M, et al. Familial gastrointestinal stromal tumours with germline mutation of the KIT gene. Nat Genet. 1998;19:323-324[CrossRef][Medline] [Order article via Infotrieve].
11.
Kim CH, Broxmeyer HE.
In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, Steel factor, and the bone marrow environment.
Blood.
1998;91:100-110
12.
Meininger CJ, Yano H, Rottapel R, Bernstein A, Zsebo KM, Zetter BR.
The c-kit receptor ligand functions as a mast cell chemoattractant.
Blood.
1992;79:958-963 13. Nilsson G, Butterfield JH, Nilsson K, Siegbahn A. Stem cell factor is a chemotactic factor for human mast cells. J Immunol. 1994;153:3717-3723[Abstract].
14.
Duronio V, Welham MJ, Abraham S, Dryden P, Schrader JW.
p21ras activation via hemopoietin receptors and c-kit requires tyrosine kinase activity but not tyrosine phosphorylation of p21ras GTPase- activating protein.
Proc Natl Acad Sci U S A.
1992;89:1587-1591
15.
Serve H, Hsu YC, Besmer P.
Tyrosine residue 719 of the c-kit receptor is essential for binding of the P85 subunit of phosphatidylinositol (PI) 3-kinase and for c-kit- associated PI 3-kinase activity in COS-1 cells.
J Biol Chem.
1994;269:6026-6030
16.
Cutler RL, Liu L, Damen JE, Krystal G.
Multiple cytokines induce the tyrosine phosphorylation of Shc and its association with Grb2 in hemopoietic cells.
J Biol Chem.
1993;268:21463-21465
17.
Linnekin D, DeBerry CS, Mou S.
Lyn associates with the juxtamembrane region of c-Kit and is activated by stem cell factor in hematopoietic cell lines and normal progenitor cells.
J Biol Chem.
1997;272:27450-27455
18.
Sattler M, Salgia R, Shrikhande G, et al.
Steel factor induces tyrosine phosphorylation of CRKL and binding of CRKL to a complex containing c-kit, phosphatidylinositol 3-kinase, and p120(CBL).
J Biol Chem.
1997;272:10248-10253
19.
van Dijk TB, van Den Akker E, Amelsvoort MP, Mano H, Lowenberg B, von Lindern M.
Stem cell factor induces phosphatidylinositol 3'-kinase-dependent Lyn/Tec/Dok-1 complex formation in hematopoietic cells.
Blood.
2000;96:3406-3413
20.
Kozlowski M, Larose L, Lee F, Le DM, Rottapel R, Siminovitch KA.
SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain.
Mol Cell Biol.
1998;18:2089-2099
21.
O'Laughlin-Bunner B, Radosevic N, Taylor ML, et al.
Lyn is required for normal stem cell factor-induced proliferation and chemotaxis of primary hematopoietic cells.
Blood.
2001;98:343-350 22. Sundstrom M, Alfredsson J, Olsson N, Nilsson G. Stem cell factor-induced migration of mast cells requires p38 mitogen-activated protein kinase activity. Exp Cell Res. 2001;267:144-151[CrossRef][Medline] [Order article via Infotrieve].
23.
Daino H, Matsumura I, Takada K, et al.
Induction of apoptosis by extracellular ubiquitin in human hematopoietic cells: possible involvement of STAT3 degradation by proteasome pathway in interleukin 6-dependent hematopoietic cells.
Blood.
2000;95:2577-2585
24.
Isegawa Y, Ping Z, Nakano K, Sugimoto N, Yamanishi K.
Human herpesvirus 6 open reading frame U12 encodes a functional beta-chemokine receptor.
J Virol.
1998;72:6104-6112 25. Eddy RJ, Pierini LM, Matsumura F, Maxfield FR. Ca2+-dependent myosin II activation is required for uropod retraction during neutrophil migration. J Cell Sci. 2000;113:1287-1298[Abstract].
26.
Zia S, Ndoye A, Lee TX, Webber RJ, Grando SA.
Receptor-mediated inhibition of keratinocyte migration by nicotine involves modulations of calcium influx and intracellular concentration.
J Pharmacol Exp Ther.
2000;293:973-981
27.
Price DJ, Rivnay B, Fu Y, Jiang S, Avraham S, Avraham H.
Direct association of Csk homologous kinase (CHK) with the diphosphorylated site Tyr568/570 of the activated c-KIT in megakaryocytes.
J Biol Chem.
1997;272:5915-5920 28. Price DJ, Rivnay B, Avraham H. CHK down-regulates SCF/KL-activated Lyn kinase activity in Mo7e megakaryocytic cells. Biochem Biophys Res Commun. 1999;259:611-616[CrossRef][Medline] [Order article via Infotrieve]. 29. Timokhina I, Kissel H, Stella G, Besmer P. Kit signaling through PI 3-kinase and Src kinase pathways: an essential role for Rac1 and JNK activation in mast cell proliferation. EMBO J. 1998;17:6250-6262[CrossRef][Medline] [Order article via Infotrieve]. 30. Ronnstrand L, Heldin CH. Mechanisms of platelet-derived growth factor-induced chemotaxis. Int J Cancer. 2001;91:757-762[CrossRef][Medline] [Order article via Infotrieve]. 31. Mureebe L, Nelson PR, Yamamura S, Lawitts J, Kent KC. Activation of pp60c-src is necessary for human vascular smooth muscle cell migration. Surgery. 1997;122:138-144[CrossRef][Medline] [Order article via Infotrieve]discussion 144-135.
32.
Waltenberger J, Uecker A, Kroll J, et al.
A dual inhibitor of platelet-derived growth factor beta-receptor and Src kinase activity potently interferes with motogenic and mitogenic responses to PDGF in vascular smooth muscle cells. A novel candidate for prevention of vascular remodeling.
Circ Res.
1999;85:12-22
33.
Honda Z, Suzuki T, Hirose N, et al.
Roles of C-terminal Src kinase in the initiation and the termination of the high affinity IgE receptor-mediated signaling.
J Biol Chem.
1997;272:25753-25760
34.
Suzuki T, Shoji S, Yamamoto K, et al.
Essential roles of Lyn in fibronectin-mediated filamentous actin assembly and cell motility in mast cells.
J Immunol.
1998;161:3694-3701
35.
Egea J, Espinet C, Comella JX.
Calcium influx activates extracellular-regulated kinase/mitogen-activated protein kinase pathway through a calmodulin-sensitive mechanism in PC12 cells.
J Biol Chem.
1999;274:75-85
36.
Elzi DJ, Bjornsen AJ, MacKenzie T, Wyman TH, Silliman CC.
Ionomycin causes activation of p38 and p42/44 mitogen-activated protein kinases in human neutrophils.
Am J Physiol Cell Physiol.
2001;281:C350-C360 37. Lennartsson J, Blume-Jensen P, Hermanson M, Ponten E, Carlberg M, Ronnstrand L. Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-kit mediated activation of the Ras/MAP kinase pathway and c-fos induction. Oncogene. 1999;18:5546-5553[CrossRef][Medline] [Order article via Infotrieve]. 38. Hooshmand-Rad R, Claesson-Welsh L, Wennstrom S, Yokote K, Siegbahn A, Heldin CH. Involvement of phosphatidylinositide 3'-kinase and Rac in platelet-derived growth factor-induced actin reorganization and chemotaxis. Exp Cell Res. 1997;234:434-441[CrossRef][Medline] [Order article via Infotrieve]. 39. Kundra V, Escobedo JA, Kazlauskas A, et al. Regulation of chemotaxis by the platelet-derived growth factor receptor-beta. Nature. 1994;367:474-476[CrossRef][Medline] [Order article via Infotrieve]. 40. Wennstrom S, Siegbahn A, Yokote K, et al. Membrane ruffling and chemotaxis transduced by the PDGF beta-receptor require the binding site for phosphatid |
Top
Abstract
Introduction
1, the
Grb2 adaptor protein,
p85) and analyzed for SCF-induced
Ca2+ influx (SCF; 100 ng/mL). (D) Dominant-negative PI3K
inhibits SCF-induced cell migration. BAF3/KIT cells stably transfected
with 
oncogenic activation of v-kit involves deletion of extracellular domain and C terminus.
EMBO J.
1988;7:1003-1011